15-65916253-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001385028.1(MEGF11):āc.2239A>Gā(p.Lys747Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000034 in 1,556,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001385028.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MEGF11 | NM_001385028.1 | c.2239A>G | p.Lys747Glu | missense_variant | 18/26 | ENST00000395614.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MEGF11 | ENST00000395614.6 | c.2239A>G | p.Lys747Glu | missense_variant | 18/26 | 5 | NM_001385028.1 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000183 AC: 3AN: 164312Hom.: 0 AF XY: 0.0000231 AC XY: 2AN XY: 86674
GnomAD4 exome AF: 0.0000299 AC: 42AN: 1404832Hom.: 0 Cov.: 32 AF XY: 0.0000260 AC XY: 18AN XY: 693366
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2022 | The c.2239A>G (p.K747E) alteration is located in exon 18 (coding exon 17) of the MEGF11 gene. This alteration results from a A to G substitution at nucleotide position 2239, causing the lysine (K) at amino acid position 747 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at